Home » Posts tagged 'Margaret Darling'
By Steven Lieberman on September 12, 2017In Health Policy, Pharmaceutical Policy and Regulation.
Opportunities exist to lower spending on generic drugs—and reduce total health care spending.
By Steven Lieberman on February 10, 2017In Health Care Delivery, Health Care Markets, Health Policy.
MACRA assumes a wide range of attractive APM opportunities available to physicians, but the reality is that the opportunities are limited, especially for physicians in specialties outside of primary care. (more…)